Physician profile
Shirin Razdan
NPI 1053815621
$21,235.41
in general payments reported to CMS, 2019-2025
13 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,181 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,711 · Travel and Lodging: $1,866 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,650.00 |
| Food and Beverage | $4,711.07 |
| Travel and Lodging | $1,865.60 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $14,972.16 | 2025 | |
| Intuitive Surgical, INC. | $2,578.21 | 2024 | |
| Boston Scientific Corporation | $1,420.65 | 2024-2025 | Ams 700, General - Erectile Dysfunction, Rezum Generator |
| Mimedx Group, INC. | $923.98 | 2025 | |
| Coloplast Corp | $708.79 | 2024-2025 | |
| Procept Biorobotics Corporation | $275.28 | 2024-2025 | Aquabeam System |
| Profound Medical Corp. | $172.98 | 2025 | Tulsa-Pro |
| Medtronic, INC. | $46.22 | 2024 | |
| Laborie Medical Technologies Corp. | $29.42 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $29.25 | 2025 | |
| Endo USA, INC. | $28.73 | 2025 | Xiaflex |
| Tela Bio, INC. | $26.12 | 2024 | Ovitex 2s |
| Telix Pharmaceuticals | $23.62 | 2025 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirin Razdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.